Sendai virus-based immunoadjuvant in hydrogel vaccine intensity-modulated dendritic cells activation for suppressing tumorigenesis

The conventional immunoadjuvants in vaccine have weak effect on stimulating antigen presentation and activating anti-tumor immunity. Unexpectedly, we discovered that non-pathogenic Sendai virus (SeV) could activate antigen-presenting cells (APCs) represented by dendritic cells (DCs). Here, we design...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bin Zheng, Wenchang Peng, Lin Gan, Mingming Guo, Shuchao Wang, Xiao-Dong Zhang, Dong Ming
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	KeAi Communications Co., Ltd. 2021-11-01
Edice:	Bioactive Materials
Témata:	Hydrogel vaccine Sendai virus (SeV) Immunoadjuvant Dendritic cells Immunoprotection
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2452199X21001596
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!